Molecular characterization of a ceftazidime-resistant Morganella morganii isolate producing a TEM-10 β-lactamase [2]

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 434-435

  Barroso, H ^a   Freitas Vieira, A ^a   Duarte, A ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAMASE; CEFTAZIDIME; GENTAMICIN; NALIDIXIC ACID; NETILMICIN;

ANTIBIOTIC RESISTANCE; BACTERIUM CONJUGATION; ESCHERICHIA COLI; LETTER; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0033022824     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.434     Document Type: Letter

References (11)

1. Ambler, R. P., F. W. Coulson, J. M. Frere, J.-M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-272.
2. Bradford, P. A., C. E. Cherubin, V. Idemyor, B. A. Rasmussen, and K. Bush. 1994. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrob. Agents Chemother. 38:761-766.
3. Coudron, P. E., E. S. Moland, and C. C. Sanders. 1997. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a Veterans medical center: seek and you may find. J. Clin. Microbiol. 35:2593-2597.
4. Courvalin, P., F. Goldstein, A. Philippon, and J. Sirot (ed.). 1985. L'antibiogramme. MPC Vidéom, Paris, France.
5. Hibbert-Rogers, L. C. F., J. Heritage, N. Todd, and P. M. Hawkey. 1994. Convergent evolution of TEM-26, a β-lactamase with extended-spectrum activity. J. Antimicrob. Chemother. 33:707-720.
6. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
7. Monnet, D., and C. Richard. 1994. Autres Enterobacteriaceae, p. 1053-1128. In J. Freney, F. Renaud, W. Hansen, and C. Bollet (ed.), Manuel de bacteriologie clinique, 2nd ed. E. S. Elsevier, Paris, France.
8. Palzkill, T., K. S. Thomson, C. C. Sanders, E. S. Moland, W. Huang, and T. W. Milligan. 1995. New variant of TEM-10 β-lactamase gene produced by a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 39: 1199-1200.
9. Rasmussen, B. A., P. A. Bradford, J. P. Quinn, J. Wiener, R. A. Weinstein, and K. Bush. 1993. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 β-lactamases encoded by different nucleotide sequences. Antimicrob. Agents Chemother 37:1989-1992.
10. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 74:3737-3741.
11. Tessier, F., C. Arpin, A. Allery, and C. Quentin. 1998. Molecular characterization of a TEM-21 β-lactamase in a clinical isolate of Morganella morganii. Antimicrob. Agents Chemother. 42:2125-2127.